Back to methods browser

First-pass extracted concept

all-optical platforms

Candidate: toolkit itemType: assay method1 source documents2 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

All-optical platforms generate electrophysiological data without invasive contact-based measurements. The review highlights them as useful for high-throughput variant stratification and drug discovery in iPSC-CM systems.

Source 1DOIPubMed

Resources required

They require an all-optical electrophysiology setup and compatible iPSC-CM assay formats. The abstract does not specify the exact optical reporters or stimulation hardware.

Source 1DOIPubMed

What problem it solves

They address the need for non-invasive, high-throughput electrophysiological phenotyping in arrhythmia modeling. This supports scalable screening and variant assessment.

Source 1DOIPubMed

What it does not solve

The abstract does not state that all-optical platforms alone fix iPSC variation, editing toxicity, or maturity limitations. Their role is primarily phenotyping and screening.

Source 1DOIPubMed

Alternatives

The abstract does not name a specific alternative assay, but positions all-optical platforms as an advantageous readout approach within iPSC-CM workflows.

Source 1DOIPubMed

Evidence Snippets

all-optical platforms provide non-invasive and high-throughput electrophysiological data that is useful for stratification of emerging arrhythmogenic variants and drug discovery
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1assay capabilitysupports2024Source 1DOIPubMed

All-optical platforms provide non-invasive and high-throughput electrophysiological data useful for stratifying emerging arrhythmogenic variants and for drug discovery.

Claim 2workflow synthesissupports2024Source 1DOIPubMed

A synergistic combination of iPSCs, gene editing, 3D culture models, and all-optical platforms is proposed as a high-throughput template to recapitulate in vitro arrhythmogenic events for personalized monitoring and drug screening.